Target intelligence / Profile preview

DNA topoisomerase 1–DNA cleavage complex (TOP1cc) (TOP1cc)

Target
TOP1cc
Molecular classification
Enzyme-DNA complex, Type IB topoisomerase, DNA-binding protein complex
01

Overview

The DNA topoisomerase 1–DNA cleavage complex (TOP1cc) is a transient intermediate formed during the catalytic cycle of DNA topoisomerase 1 (TOP1), an essential enzyme that relieves torsional strain in DNA during replication and transcription (Pommier, 2006, Nature Reviews Cancer). TOP1 functions by creating a single-strand break, forming a covalent phosphotyrosyl bond with the 3' end of the DNA, allowing the strand to rotate before religation (UniProt P11387). In the presence of TOP1 inhibitors like camptothecins, these complexes are stabilized and persist on the DNA, a process known as 'trapping' (Thomas et al., 2004, Chemical Reviews). When DNA or RNA polymerases collide with these trapped TOP1cc, they generate irreversible double-strand breaks, which ultimately lead to cell cycle arrest and programmed cell death (Pommier, 2013, Nature Reviews Drug Discovery). Because rapidly dividing cancer cells rely heavily on TOP1 for genomic stability, TOP1cc is a major therapeutic target in oncology, particularly for colorectal and lung cancers. However, the effectiveness of targeting TOP1cc can be limited by DNA repair enzymes like TDP1, which can resolve these complexes, and safety concerns often involve systemic toxicities such as myelosuppression and severe diarrhea (StatPearls, 2023).

Other names
Topoisomerase I–DNA covalent complexTOP1-DNA covalent complexTOP1 cleavage complexTopoisomerase 1-DNA complex
02

Mechanism of action

Stabilization and trapping of the transient TOP1-DNA covalent intermediate, preventing DNA religation and causing lethal double-strand breaks upon collision with replication forks (Pommier, 2006, Nature Reviews Cancer).

03

Biological functions

DNA relaxation (UniProt P11387)DNA replication (Pommier, 2006, Nature Reviews Cancer)Transcription (Pommier, 2006, Nature Reviews Cancer)DNA repair (Pommier, 2013, Nature Reviews Drug Discovery)Chromatin remodeling (UniProt P11387)
04

Disease associations

Cancer (Colorectal cancer, Ovarian cancer, Small cell lung cancer)
05

Safety considerations

Myelosuppression (Neutropenia, Anemia)Severe diarrhea (Gastrointestinal toxicity)Secondary malignanciesCholinergic syndrome (with irinotecan)
06

Interacting drugs

Irinotecan

7 more in the full profile.

07

Biomarkers

SLFN11 expression (Murai et al., 2012, Cancer Research)TDP1 activity (Pommier, 2006, Nature Reviews Cancer)TOP1 protein expression levelsXRCC1 expression

Beyond the preview

Go deeper on DNA topoisomerase 1–DNA cleavage complex (TOP1cc) (TOP1cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA topoisomerase 1–DNA cleavage complex (TOP1cc) (TOP1cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call